Utah Medical Products (NASDAQ:UTMD – Get Free Report) was downgraded by investment analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday.
Utah Medical Products Stock Up 1.0 %
Shares of UTMD stock opened at $67.91 on Thursday. Utah Medical Products has a 52 week low of $63.38 and a 52 week high of $87.86. The company has a market cap of $236.33 million, a P/E ratio of 15.90 and a beta of 0.08. The business has a 50 day moving average of $65.98 and a two-hundred day moving average of $67.31.
Hedge Funds Weigh In On Utah Medical Products
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Copeland Capital Management LLC acquired a new position in Utah Medical Products during the 3rd quarter worth $53,000. Allspring Global Investments Holdings LLC bought a new position in Utah Medical Products in the 2nd quarter valued at about $83,000. Victory Capital Management Inc. increased its stake in Utah Medical Products by 124.4% during the 2nd quarter. Victory Capital Management Inc. now owns 2,673 shares of the medical instruments supplier’s stock valued at $179,000 after buying an additional 1,482 shares during the period. EntryPoint Capital LLC raised its position in shares of Utah Medical Products by 124.1% during the 1st quarter. EntryPoint Capital LLC now owns 3,240 shares of the medical instruments supplier’s stock worth $230,000 after buying an additional 1,794 shares in the last quarter. Finally, GSA Capital Partners LLP acquired a new stake in shares of Utah Medical Products in the 3rd quarter worth approximately $231,000. 69.60% of the stock is owned by institutional investors.
Utah Medical Products Company Profile
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Stories
- Five stocks we like better than Utah Medical Products
- Dividend Payout Ratio Calculator
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- ETF Screener: Uses and Step-by-Step Guide
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.